PS
GMED icon

Planning Strategies’s Globus Medical GMED Stock Holding History

Planning Strategies’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$553 Buy
+7
New +$595 ﹤0.01% 843

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Planning Strategies's GMED Position: Q2 2026 in Review

Planning Strategies opened a new position in Globus Medical (GMED) in Q2 2026: 7 shares worth $553. The stake represents ﹤0.01% of the portfolio and ranks #843 among its holdings.

566 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Planning Strategies held 7 shares of Globus Medical worth $553 as of Q2 2026.
  • Globus Medical was a new Planning Strategies position in Q2 2026.
  • Globus Medical made up ﹤0.01% of Planning Strategies's portfolio in Q2 2026, its #843 holding.
  • 566 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Planning Strategies's 13F filing for Q2 2026, filed 27 Jul 2026.